These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 33522967)
1. Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers. Camporesi E; Lashley T; Gobom J; Lantero-Rodriguez J; Hansson O; Zetterberg H; Blennow K; Becker B Acta Neuropathol Commun; 2021 Feb; 9(1):19. PubMed ID: 33522967 [TBL] [Abstract][Full Text] [Related]
2. Tau protein profiling in tauopathies: a human brain study. Lantero-Rodriguez J; Camporesi E; Montoliu-Gaya L; Gobom J; Piotrowska D; Olsson M; Burmann IM; Becker B; Brinkmalm A; Burmann BM; Perkinton M; Ashton NJ; Fox NC; Lashley T; Zetterberg H; Blennow K; Brinkmalm G Mol Neurodegener; 2024 Jul; 19(1):54. PubMed ID: 39026372 [TBL] [Abstract][Full Text] [Related]
3. Selective tau tyrosine nitration in non-AD tauopathies. Reyes JF; Geula C; Vana L; Binder LI Acta Neuropathol; 2012 Jan; 123(1):119-32. PubMed ID: 22057784 [TBL] [Abstract][Full Text] [Related]
4. Distinct phosphorylation profiles of tau in brains of patients with different tauopathies. Samimi N; Sharma G; Kimura T; Matsubara T; Huo A; Chiba K; Saito Y; Murayama S; Akatsu H; Hashizume Y; Hasegawa M; Farjam M; Shahpasand K; Ando K; Hisanaga SI Neurobiol Aging; 2021 Dec; 108():72-79. PubMed ID: 34536819 [TBL] [Abstract][Full Text] [Related]
5. Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Arai T; Ikeda K; Akiyama H; Tsuchiya K; Iritani S; Ishiguro K; Yagishita S; Oda T; Odawara T; Iseki E Acta Neuropathol; 2003 May; 105(5):489-98. PubMed ID: 12677450 [TBL] [Abstract][Full Text] [Related]
6. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Ferrer I; Barrachina M; Puig B Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379 [TBL] [Abstract][Full Text] [Related]
7. Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies. Gibbons GS; Banks RA; Kim B; Changolkar L; Riddle DM; Leight SN; Irwin DJ; Trojanowski JQ; Lee VMY J Neuropathol Exp Neurol; 2018 Mar; 77(3):216-228. PubMed ID: 29415231 [TBL] [Abstract][Full Text] [Related]
8. Phosphorylated c-MYC expression in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Ferrer I; Blanco R; Carmona M; Puig B Neuropathol Appl Neurobiol; 2001 Oct; 27(5):343-51. PubMed ID: 11679086 [TBL] [Abstract][Full Text] [Related]
9. SCRN1: A cerebrospinal fluid biomarker correlating with tau in Alzheimer's disease. Weiner S; Sauer M; Brinkmalm G; Constantinescu J; Constantinescu R; Gomes BF; Becker B; Nellgård B; Dalla K; Galasko D; Zetterberg H; Blennow K; Gobom J Alzheimers Dement; 2023 Oct; 19(10):4609-4618. PubMed ID: 36946611 [TBL] [Abstract][Full Text] [Related]
10. Quantification of the trans-synaptic partners neurexin-neuroligin in CSF of neurodegenerative diseases by parallel reaction monitoring mass spectrometry. Camporesi E; Nilsson J; Vrillon A; Cognat E; Hourregue C; Zetterberg H; Blennow K; Becker B; Brinkmalm A; Paquet C; Brinkmalm G EBioMedicine; 2022 Jan; 75():103793. PubMed ID: 34990894 [TBL] [Abstract][Full Text] [Related]
11. AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies. Vingtdeux V; Davies P; Dickson DW; Marambaud P Acta Neuropathol; 2011 Mar; 121(3):337-49. PubMed ID: 20957377 [TBL] [Abstract][Full Text] [Related]